MENU

CRSP

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

CRISPR Therapeutics AG (CRSP) Ownership - Who owns CRISPR Therapeutics AG?

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics... Show more

Industry: #Biotechnology

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

Biotechnology

Address

Baarerstrasse 14

Phone

+41 415613277

Employees

407

Web

https://www.crisprtx.com

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

4.92B

P/E Ratio

N/A

Total Cash

1.98B

Projected Growth

N/A

Total Debt

206.75M

Revenue

N/A

Risk (Beta)

3.02

Dividend Yield

N/A

Total Cash/Share

20.58

Total Debt/Equity

N/A

Revenue/Share

null USD as % of share price

View a ticker or compare two or three

VS

VS

CRSP

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CRSP showed earnings on February 12, 2026. You can read more about the earnings report here.

View AI-Driven Trading for CRSP

A.I. Advisor

published General Information

General Information

a developer of gene-based medicines

Industry Biotechnology

Profile

Details

Industry

Biotechnology

Address

Baarerstrasse 14

Phone

+41 415613277

Employees

407

Web

https://www.crisprtx.com